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Abstract 32 
The mechanism of action of chlorogenic acid (CGA) on the formation of advanced glycation end-33 
products (AGEs) (glycoxidation reaction) was studied. Model systems composed of bovine serum 34 
albumin (BSA) (1 mg mL-1) and methylglyoxal (5 mM) under mimicked physiological conditions 35 
(pH 7.4, 37 ºC) were used to evaluate the antiglycoxidative effect of CGA (10 mM). The stability 36 
of CGA under reaction conditions was assayed by HPLC and MALDI-TOF MS. The 37 
glycoxidation reaction was estimated by analysis of free amino groups by OPA assay, spectral 38 
analysis of fluorescent AGEs and total AGEs by ELISA, and colour formation by absorbance at 39 
420 nm. Structural changes in protein were evaluated by analysis of phenol-bound to protein 40 
backbone using the Folin reaction, UV-Vis spectral analysis and MALDI-TOF-MS, while 41 
changes in protein function were measured by determining antioxidant capacity using the ABTS 42 
radical cation decolourisation assay. CGA was isomerised and oxidised under our experimental 43 
conditions. Evidence of covalent binding between BSA and multiple CGA and/or its derivatives 44 
molecules (isomers and oxidation products) was found. CGA inhibited (p < 0.05) the formation 45 
of fluorescents and total AGEs at 72 h of reaction by 91.2 and 69.7%, respectively. The binding 46 
of phenols to BSA significantly increased (p < 0.001) its antioxidant capacity. A correlation was 47 
found between free amino group content, phenol-bound to protein and antioxidant capacity. 48 
Results indicate that CGA simultaneously inhibits the formation of potentially harmful 49 
compounds (AGEs) and promotes the generation of neoantioxidant structures. 50 
 51 
 52 
 53 
 54 
 55 
 56 
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1. Introduction  57 
Protein glycation includes an initial formation of Shiff's base, followed by intermolecular 58 
rearrangement and conversion into Amadori products. They undergo further processing to form a 59 
heterogeneous group of protein-bound moieties, such as cross-linking fluorescent (e.g., 60 
pentosidine) and non-fluorescent adducts (e.g., Nε-(carboxymethyl)lysine) (CML), Nε-61 
(carboxyethyl)lysine (CEL)) called advanced glycation end products (AGEs).1 Pathways of AGE 62 
formation involve glucose autoxidation through the generation of α-oxoaldehydes, such as 63 
methylglyoxal (MGO), 3-deoxyglucosone and glyoxal. MGO is a major precursor of AGEs, 64 
especially CEL, which is capable of binding and modifying a number of proteins (glycoxidation 65 
reaction), including bovine serum albumin (BSA), RNase A, collagen, lysozyme and lens 66 
crystallins.2,3 Protein glycation is known to be involved in the pathogenesis of several age-related 67 
disorders like diabetes, atherosclerosis, end-stage renal and neurodegenerative diseases.4 68 
Inhibitors of AGEs formation might follow several mechanisms, such as aldose reductase, 69 
antioxidant activity, reactive dicarbonyl trapping, sugar autoxidation inhibition and amino group 70 
binding.5 The inhibition of AGE formation by synthetic aminoguanidine (AG) has been widely 71 
documented. However, as AG treatment in type 1 diabetics has caused serious complications, the 72 
search for natural AGE inhibitors is currently a challenge. 6  73 
Coffee and yerba mate are considered natural sources of abundant phenolic compounds  that can 74 
inhibit the formation of AGEs.7,8  The most representative phenolic acids in these foods are 75 
chlorogenic acids (CGA), which commonly occur as 5-O-caffeoylquinic acid (5-CQA) or 3-O-76 
caffeoylquinic acid (3-CQA).9,10 The antiglycation activity of CGA has been associated to its 77 
antioxidant and chelating characters, as well as to its ability to trap reactive dicarbonyl 78 
compounds.8,11 This study aimed to obtain a better understanding of the antiglycoxidative 79 
mechanism of action of CGA which is partly unknown. In vitro studies mimicking physiological 80 
conditions were performed to achieve this goal.  81 
2. Materials and methods 82 
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2.1 Materials 83 
All chemicals and solvents were of analytical grade. Bovine serum albumin (BSA), phosphate 84 
buffered saline (PBS), 3-O-caffeoylquinic acid (CGA), sodium azide, ortho-phthaldialdehyde 85 
(OPA), Nα-acetyl-L-lysine, Folin-Ciocalteau, 3.3′, 5.5′-Tetramethylbenzidine (TMB) were from 86 
Sigma–Aldrich (St. Louis, USA). Other chemicals and their suppliers were as follows: β-87 
mercaptoethanol (Merck, Hohenbrunn, Germany), methylglyoxal solution (MGO) and 2.2’-88 
azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS) (Fluka, Buchs, 89 
Switzerland) and Bradford reagent for protein assay (Bio-Rad, München, Germany). The 90 
Amicon® Ultra- 0.5 ml centrifugal filter unit fitted with an Ultracel®-30K regenerated cellulose 91 
membrane (30 kDa cut-off) was from Merck Millipore Ltd. (Tullagreen, Cork, Ireland). Microtest 92 
96-well plates made from high-quality polystyrene were purchased from Sarstedt AG & Co. 93 
(Nümbrecht, Germany). The Costar® high binding 96-well EIA/RIA plate was from Corning 94 
Incorporated (Corning, NY, USA). The Milli-Q water used in this study was obtained using a 95 
purification system (Millipore, Molsheim, France).  96 
2.2 Formation of CGA derivatives in control samples  97 
2.2.1 HPLC analysis 98 
Standard CGA before and after incubation at 37 ºC for 24 h were compared to assess the chemical 99 
stability of the compound under experimental conditions by reversed phase (RP) HPLC. A 100 
modular chromatographer HP 1100 (Agilent Technologies, Paolo Alto, CA, USA) equipped with 101 
a multi-waves UV-Vis detector was used to analyse  samples. The stationary phase was a 250 x 102 
2.1 mm i.d. C18 RP column, particle diameter 4 μm (Jupiter Phenomenex, Torrance, CA, USA). 103 
Column temperature was maintained at 37 °C during the HPLC analyses. Separations were carried 104 
out at a constant flow rate of 0.2 mL min-1 applying a 5-60% linear gradient of solvent B 105 
(acetonitrile/ 0.1% trifluoroacetic acid, TFA) over 60 min, after 5 min of isocratic elution at 5% 106 
solvent B. Solvent A was 0.1% TFA in HPLC-grade water. For each run, 2.5 μg standard or 107 
incubated CGA were diluted 10-fold with 0.1% TFA and injected using a Rheodyne® valve. The 108 
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HPLC separations were monitored at 280, 320 and 360 nm, while UV-Vis spectra (200-600 nm) 109 
were recorded using a diode array detector. 110 
2.2.2 MALDI-TOF-MS analysis 111 
Mass spectra of CGA freshly prepared and incubated at 37 ºC for 24 h were acquired on a 112 
Voyager DE-Pro spectrometer (PerSeptive BioSystems, Framingham, Massachusetts) equipped 113 
with a N2 laser (λ= 337 nm) operating in both positive and negative reflector ion modes. The 114 
matrix was 2.5- hydroxybenzoic acid (DHB) 10 mg mL-1 in 50% acetonitrile. In the positive ion 115 
mode, the matrix solution also contained 0.1% TFA. Spectra were acquired using Delay 116 
Extraction technology at an accelerating voltage of 20 kV, exploring the m/z 150−1200 range. 117 
Matrix ion signals were excluded by separately acquiring positive and negative spectra of DHB. 118 
The mass range was externally calibrated with a mixture of standard polyphenols (Sigma, Milan, 119 
Italy). Spectra were elaborated with Data Explorer 4.0. 120 
2.3 In vitro glycoxidation of proteins 121 
Model systems were composed of BSA at a final concentration of 1 mg mL-1 in 0.01 M PBS 122 
buffer (pH 7.4) added with sodium azide (0.05%) and MGO (5 mM). Glycoxidation model 123 
systems were prepared in the presence or absence of the inhibitor (CGA 10 mM). Prior to 124 
initiation of the glycoxidation reaction by addition of MGO, the pH values of all solutions were 125 
measured at 25 °C using an electrode pH-meter (Metler Toledo, Spain) to ensure optimal and 126 
equal conditions of reaction in all samples (pH=7.4). The model systems were incubated at 37 °C 127 
for 192 h, and samples were taken after 24, 72, 96 and 192 h. The glycoxidation reaction was 128 
stopped by cooling in an ice bath. All samples were prepared in triplicate. A control solution of 129 
BSA was also included. The progress of the glycoxidation reaction was determined by analysing 130 
free amino groups, AGEs and brown compounds. 131 
 132 
2.3.1 Free amino groups 133 
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Free protein amino groups (both N-terminal and epsilon -NH2 of lysine) were determined by the 134 
OPA assay, following Go et al.12 OPA reagent was freshly prepared by dissolving 10 mg of OPA 135 
in 250 μL of 95% (v/v) ethanol and adding 9.8 mL of 0.01 M PBS pH 7.4 and 20 μL of β-136 
mercaptoethanol. The total volume of reaction was 250 μL. The reaction was carried out in 137 
transparent polystyrene 96-well microtest plate (No. 82.1581). Fluorescence was read after the 138 
addition of OPA reagent on a microplate fluorescence reader Biotek Synergy™ HT (Biotek 139 
Instruments, Highland Park, Winooski, USA) with excitation at 360 ± 40 nm and emission at 460 140 
± 40 nm. Fluorescence was read every 53 s for 15 min. Calibration curves were constructed using 141 
standard solutions of Nα-acetyl-L-lysine (0.025-1 mM). All measurements were performed in 142 
triplicate, and data were expressed as µg Nα-acetyl-L-lysine equivalent per mg of protein. 143 
 144 
2.3.2 AGEs  145 
AGE formation was monitored by fluorescence spectrophotometry using a Biotek microplate 146 
spectrophotometer at 360 ± 40 nm and 460 ± 40 nm as excitation and emission wavelengths, 147 
respectively. No dilution was required for the glycoxidation model or the control systems. All 148 
measurements were performed in triplicate. 149 
The formation of total AGEs-BSA was measured by an indirect ELISA assay in samples 150 
incubated for 72 h. A high affinity protein 96-well microplate was coated overnight (4° C) with 151 
100 µL of protein samples in 0.01 M phosphate buffer (pH 7.4) (5 µg mL-1). Unbound proteins 152 
were washed out with buffer PBS-T (PBS 0.01 M; Tween 0.05%), the wells were blocked with 153 
gelatin 0.5% for 1 h at room temperature,  then washed out with PBS-T, and the primary antibody 154 
(dilution 1:1000) was added for 1 h. A polyclonal rabbit IG antibody which rose against AGEs 155 
(AGE 102-0.2, Biologo, Kroshagen, Germany) was used as the primary antibody. After 1 h 156 
incubation and five washing steps, the secondary horse radish peroxidise-conjugated mouse anti-157 
rabbit IgG antibody (ABIN376294, antibodies-online Inc.,Suite, Atlanta) diluted 1:4000 in 158 
washing buffer PBS-T was added, incubated for 1 h and washed again.  Colour was developed 159 
with TMB (100 µL) and absorbance was read at 650 nm. Values were estimated by comparison 160 
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with a standard curve of glycated BSA (Methylglyoxal-AGE-BSA, CY-R2062, CircuLexTM, 161 
CycLex Co., Ltd, Nagano, Japan). All measurements were performed in triplicate, and results 162 
were expressed as µg of AGEs-BSA per mg of protein. 163 
2.3.3 Brown pigments  164 
Formation of brown pigments in the samples was estimated by measuring absorbance at 420 nm 165 
of the samples at 24, 72, 96 and 192 h, using microplate reader BioTek PowerWave™ XS. 166 
Samples were analysed in triplicate. 167 
2.4 Structural changes of proteins 168 
Prior to analysis, the protein fraction of samples incubated at 37 ºC for 72 h was isolated by 169 
ultrafiltration. Samples (0.4 mL) were placed in the sample reservoir of an Amicon® Ultra- 0.5 mL 170 
centrifugal filter unit fitted with an Ultracel®-30K regenerated cellulose membrane (30 kDa cut-171 
off) (Millipore Ltd., Ireland) and centrifuged at 14000 g for 40 min at room temperature. The 172 
concentrated samples were recovered and diluted in PBS (0.4 mL). Protein concentration was 173 
determined by the Bradford micromethod. The isolated protein fraction was used for structural and 174 
functional characterisation.  175 
2.4.1 UV-Vis spectra 176 
A Biotek microplate UV-Vis spectrophotometer equipped with UV KC junior software (Biotek) 177 
was used. The spectrum of fractionated samples was measured at 200-790 nm using a quartz 96-178 
well microplate.  179 
2.4.2 Total phenolic compounds 180 
Total phenolic content (TPC) of the isolated fraction incubated for 72 h was determined using the 181 
Folin-Ciocalteu method as described by Singleton et al.13 adapted to a microplate reader. The 182 
reduction reaction was carried out in 210 µL total volume in 96-well microplates (No. 82.1581). 183 
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A 10 µL of sample (appropriately diluted when necessary) was added to 150 µl volume of Folin-184 
Ciocalteu reagent (diluted 1:14, v/v) in Milli-Q water. After exactly 3 minutes, 4 mL of 75 g L-1 185 
sodium carbonate solution and 6 mL of water were mixed, and 50 µL of this mixture was added 186 
to each well. Absorbance at 750 nm was recorded using a microplate reader BioTek 187 
PowerWave™ XS. Calibration curves were constructed using standard solutions of CGA (0.1-1 188 
mg L-1), and results were expressed as µg CGA mL-1. 189 
2.4.3 MALDI-TOF-MS analysis 190 
MALDI-TOF mass spectra of samples incubated for 72 h were acquired in the linear positive ion 191 
mode using Voyager DE-Pro spectrometer (PerSeptive BioSystems, Framingham, 192 
Massachusetts). The accelerating voltage was 25 kV. Sinapinic acid (10 mg L-1 in 50% 193 
acetonitrile/TFA 0.1%) was used as the matrix. Spectra were externally calibrated using a 194 
commercial protein mixture provided by the instrument manufacturer (PerSeptive Biosystems, 195 
Framingham, Massachusetts).  196 
2.5 Functionality changes in proteins 197 
The antioxidant capacity of samples incubated for 72 h was estimated by the ABTS•+ 198 
decolourisation assay as described by Oki et al.14 2.2’-azino-bis (3-ethylbenzothiazoline-6-199 
sulfonic) acid radical cations (ABTS•+) were produced by reacting 7 mM ABTS stock solution 200 
with 2.45 mM potassium persulfate and allowing the mixture to stand in the dark at room 201 
temperature for 12-16 h before use. The ABTS•+ solution (stable for 2 d) was diluted in 5 mM 202 
PBS pH 7.4 (1:16 v/v) to an absorbance of 0.70 ± 0.02 at 734 nm. Each sample was dissolved in 203 
phosphate buffer (5 mM, pH 7.4) at 0.1 mg L-1. Thirty µL of test sample and 200 µL of diluted 204 
ABTS•+ solution were mixed. Absorbance of the samples at 734 nm was measured at 10 min of 205 
reaction using BioTek Power Wave™ XS microplate reader. CGA at concentrations of 0.015-0.2 206 
mM was used for calibration.  207 
2.6 Statistical analysis 208 
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Data were expressed as mean ± standard deviation (SD). Analysis of Variance (more than 2 209 
groups), one-way and two-way ANOVA followed by Bonferroni test, were applied to determine 210 
differences between means. Differences were considered to be signiﬁcant at p < 0.05. 211 
Relationships between the analysed parameters were evaluated by computing Pearson linear 212 
correlation coefficients setting the level of significance at p < 0.001. 213 
 214 
3. Results  215 
3.1  Formation of CGA derivatives 216 
Fig. 1a compares the HPLC chromatograms of standard CGA before (lower panel) and after 217 
incubation at pH 7.4, 37 ºC for 24 h (upper panel). Peaks were assigned based on retention times 218 
and UV-Vis spectra. Under our experimental conditions, CGA was converted into two isomers, 219 
namely neochlorogenic acid (trans-5-O-Caffeoylquinic acid) and cryptochlorogenic acid (4-O-220 
Caffeoylquinic acid). 221 
The MALDI-TOF-MS (Fig. 1b) demonstrated the co-occurrence of the hydroquinone and 222 
quinone forms ([M + H]+ m/z 353 and m/z 355, and [M + Na]+ m/z 375 and m/z 377, respectively) 223 
along with the dimeric adducts ([2M + Na]+ m/z 729 and m/z 731), as assigned in the Table 1. No 224 
CGA homopolymers were detected by either HPLC or MALDI-TOF-MS. 225 
 226 
3.2 Progress of the glycoxidation reaction 227 
The  availability of  free amino groups was obtained by OPA assay (Fig. 2). Incubation of BSA 228 
alone at 37 ˚C for 192 h did not significantly affect (p > 0.001) the availability of free amino 229 
groups, indicating the absence of inter-protein cross-linking events. Incubation in the presence of 230 
MGO produced a significant decrease (p < 0.001) in BSA free amino groups during the incubation 231 
period, suggesting that the glycoxidation reaction occurred. Interestingly, the addition of CGA to 232 
the glycoxidation mixture (BSA+MGO) also caused a significant decrease (p < 0.001) in available 233 
free amino groups throughout the whole incubation period.  Available free amino groups also 234 
decreased when BSA was incubated with CGA alone compared to the protein control and did not 235 
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significantly differ (p > 0.001) from those of the inhibition model composed of BSA, MGO and 236 
CGA.  237 
Fig. 3 illustrates the formation of fluorescent AGEs during 192 h of glycoxidation reaction. As 238 
expected, the protein control (BSA alone) showed very low fluorescence intensity throughout the 239 
experiment, due to intrinsic fluorescence caused by the presence of fluorescent amino acids in the 240 
protein backbone. The reaction of BSA and MGO produced a significant formation (p < 0.05) of 241 
fluorescent AGEs in a time dependent manner. The presence of CGA efficiently inhibited (p < 242 
0.05) fluorescent AGE formation in the glycoxidation model system, while the reaction of BSA 243 
and CGA caused a minor formation of fluorescent compounds. Further and more precise 244 
information regarding the generation of total AGEs, both fluorescent and non-fluorescence 245 
adducts, under our experimental conditions was obtained by indirect ELISA (Table 2). The results 246 
are consistent with those obtained by fluorescence monitoring. BSA data are considered basal 247 
values for all model systems. AGE generation was significantly (p < 0.05) inhibited by the 248 
presence of CGA in the glycoxidation system.  249 
Fig. 4 shows the generation of brown compounds. Absorbance values at 420 nm of mixtures 250 
composed of BSA alone and BSA+MGO were very low and not significantly different (p > 0.05) 251 
in any case. The presence of CGA in the model systems induced significant brown compound 252 
formation in a time dependent manner. High and similar levels of browning (p > 0.05) were found 253 
in model systems composed of CGA alone and BSA+CGA. The extent of brown compound 254 
formation in samples composed of BSA, MGO and CGA was significantly lower (p < 0.05) than 255 
in the other samples containing CGA.  256 
3.3 Structural changes of protein  257 
Since significant AGE formation was observed after 72 h of glycoxidation reaction (Fig. 3 and 258 
Table 2), those samples were selected for further characterisation. As shown in Fig. 5a, fresh and 259 
incubated (37 ˚C for 72 h) BSA solutions exhibited identical UV-Vis spectra, suggesting that no 260 
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structural modifications of proteins occurred following heating. Furthermore, the glycoxidation 261 
reaction BSA+MGO did not alter the UV-Vis spectrum compared to fresh BSA. In contrast, the 262 
protein fraction isolated from the glycoxidation mixture with CGA showed a very different 263 
spectrum than that found for the control (BSA) and was very similar to the spectrum of BSA 264 
incubated with CGA. 265 
Total phenolic content of the samples incubated at pH 7.4, 37 ºC for 72 h is shown in Fig. 5b. As 266 
expected, significant levels (p < 0.05) of phenolic compounds were detected in the protein 267 
fractions isolated from the CGA model systems, namely BSA + CGA and BSA + MGO + CGA.  268 
MALDI-TOF-MS analysis was performed to confirm the formation of covalent bindings of CGA 269 
to the protein backbone at 72 h (Fig. 6). In the spectra corresponding to BSA incubated with 270 
MGO, the characteristic peak of BSA was clearly visible with variable mass increases (Fig. 6b). 271 
Greater mass shifts were observed when BSA was incubated with CGA either in the absence (Fig. 272 
6c) or presence of MGO (Fig. 6d). The mass data suggested that, BSA binds several molecules of 273 
CGA and its derivatives in addition to the MGO in these samples, forming a heterogeneous 274 
mixture of protein conjugates as reflected by the broadening of BSA peaks (Fig. 6c and 6d). 275 
3.4 Changes of protein function  276 
The antioxidant capacity of the isolated protein fractions obtained from samples incubated at 37 277 
ºC for 72 h is shown in Fig. 7. The reaction with MGO did not modify the antioxidant capacity of 278 
BSA. The addition of CGA to reaction mixtures caused the formation of compounds (MW > 30 279 
kDa) which had antioxidant capacity values of 303.07 and 309.89 μg eq-CGA mL-1 for model 280 
system composed of BSA+MGO+CGA and BSA+CGA, respectively. 281 
3.5. Correlation between parameters  282 
A significant negative correlation (r=-0.754, p < 0.001) between data corresponding to free amino 283 
groups and antioxidant capacity was observed for samples incubated at 37 ºC for 72h.  A 284 
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significant negative correlation (r=-0.689, p < 0.001) was also found between free amino groups 285 
and total phenolic content.  286 
4. Discussion  287 
In this work we observed that structural changes in CGA produced in vitro under mimicked 288 
physiological conditions may contribute to the antiglycoxidative properties of this compound.  289 
Isomerisation of CGA (3-O-caffeoylquinic acid) was induced at pH 7.4 and 37 ºC. The formation 290 
of neochlorogenic (trans-5-O-caffeoylquinic acid) and cryptocholorogenic (4-O-caffeoylquinic 291 
acid) acid from CGA under similar reaction conditions has previously been reported.15,17 CGA 292 
derivatives such as oxidation products and isomers might be able to act as substrate or/and 293 
precursors of the Maillard and polymerisation reactions. 18 The formation of mono-quinones and 294 
dimer quinones was also observed in CGA incubated at pH 7.4 and 37 ºC for 24 h. This is in 295 
agreement with the non-enzymatic oxidation of CGA described by Rawel et al.19 296 
Brown compounds may be formed by the Maillard reaction, oxidation of phenols and phenol 297 
polymerisation.18 Our data suggest that the Maillard and phenol oxidation reactions are the main 298 
pathways leading to the formation of brown compounds under our experimental conditions. Both 299 
CGA and its derivatives are able to react with BSA via the Maillard reaction. However, further 300 
studies are needed to determine the chemical nature of new-formed coloured compounds.  301 
The observed decrease in the formation of AGEs in the presence of CGA demonstrates the 302 
antiglycative activity of this compound.  On the other hand, our results suggest conjugation of 303 
CGA or its derivatives to free amino groups.  A significant negative correlation between content 304 
of free amino groups and phenolic compounds was found. These results are in agreement with 305 
Rawel et al.20 who reported a decrease in lysine residues due to the reaction of BSA and CGA at 306 
room temperature for 24 h.  CGA isomers and quinones can interact with proteins forming non-307 
covalent and covalent bonds through the Maillard Reaction18. Phenolics bind highly nucleophilic 308 
thiol, amine groups and hydrophobic aromatic groups of proteins.21 Three potential types of non-309 
covalent interactions between hydroxycinnamic acids and proteins have been proposed: hydrogen, 310 
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hydrophobic, and ionic binding. 22 Prigent et al.21 found that oxidised CGA induced covalent 311 
modification of α-lactalbumin and lysozyme.  312 
Soft ionization MS techniques such as MALDI are useful to evaluate the hydroxycinnamates 313 
(HCA) covalently bound to proteins.20 MALDI-TOF-MS data suggest the formation of 314 
neoformed protein-phenol conjugates, inducing MS increments of 1.7 and 1.3 kDa in samples 315 
corresponding to BSA+CGA and BSA+CGA+MGO, respectively. The increase of molecular 316 
mass is indicative of covalent binding between CGA and/or its derivatives to the protein structure. 317 
Data on MALDI-TOF-MS support the data obtained on free amino groups, phenolic compounds 318 
and UV-Vis spectra.  319 
The formation of complexes by covalent binding of other reactive phenols such as quercetin to 320 
BSA exhibiting antioxidant potential have been previously reported.23,24 Quercetin and CGA share 321 
a high binding affinity for BSA. The ability of these two compounds to form covalent complexes 322 
polyphenol-BSA under physiological conditions has been demonstrated.25,26 Our results show that 323 
CGA causes the neoformation of molecules with antioxidant capacity.  324 
Gugliucci et al.8 previously associated the inhibitory capacity against formation of fluorescent 325 
AGEs of Ilex paraguariensis extracts to the presence of CGA. The inhibitory capacity of CGA 326 
was linked to its antioxidant character, chelating properties to transition metals ions, quenching of 327 
carbonyl radical species and AGE crosslinking.27-29 Other authors have also shown the ability of 328 
CGA to inhibit in vitro BSA glycation induced by fructose and glucose and the formation of AGE 329 
crosslinking from collagen.11 We have recently reported that MGO is effectively trapped by CGA 330 
with an IC50 of 0.14 mg mL-1.30 In addition to this mechanism, we propose for the first time a 331 
relationship between the high binding capacity of CGA to BSA and its antiglycoxidative 332 
mechanism of action. The covalent interactions suggest MGO and GCA are competing for reactive 333 
protein sites (free amine group). This effect prevents MGO from binding to BSA resulting in an 334 
effective decrease in AGE formation. 335 
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Coffee is the major source of CGA on the worldwide diet. CGA from coffee has shown a high 336 
bioavailability in humans.31 Previous studies suggest that consumption of coffee acutely increases 337 
the concentrations of phenolic compounds in LDL cholesterol particles and platelets, increases ex 338 
vivo resistance to LDL oxidation, and reduces platelet aggregation in healthy volunteers. 32,33 339 
These results support formation of antioxidant polyphenol-protein complexes in vivo and ex vivo 340 
with health promoting properties. Formation of polyphenol-protein complexes in vivo is feasible 341 
and it may be associated to a reduction of risk of diabetes complications such as cardiovascular 342 
disease. 343 
In summary, the covalent conjugation of CGA and its derivatives (isomers and quinones) to side-344 
chains of protein lysine residues reduces the formation of potentially harmful compounds, also 345 
called AGEs, and promotes the generation of antioxidant structures, which may be beneficial for 346 
human health. 347 
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Table 1: MALDI-TOF MS assignments of CGA derivatives. 461 
m/z Assignment 
353.5 [CGA*+H]+ quinone 
355.5 [CGA+H]+ 
375.3 [CGA+Na]+ quinone 
377.5 [CGA+Na]+ 
393.3 [CGA+K]+ 
399.3 [CGA+2Na]+ 
415.3 [CGA+Na+K]+ 
531.4 DHB (matrix) adducts 
547.4 DHB (matrix) adducts 
551.4 DHB (matrix) adducts 
729.6 [CGA+CGAquinone+Na]+ 
751.6 [CGA+CGAquinone+2Na]+ 
775.6 [CGA+CGAquinone+3Na]+ 
*CGA includes the isomers of chlorogenic acid that are undistinguishable 462 
                 by mass spectrometry. 463 
 464 
 465 
 466 
 467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
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Table 2: Content of total AGEs in samples corresponding to control (BSA), BSA with MGO 475 
(BSA+MGO), BSA with MGO and CGA (BSA+MGO+CGA) and BSA with CGA (BSA+CGA) 476 
incubated at pH 7.4 and 37 ºC for 72 h. Concentrations assayed were 1mg mL-1 BSA, 5 mM MGO 477 
and 10 mM CGA. BSA data are considered as initial values. 478 
 479 
 480 
 481 
 482 
 483 
Each value represents the mean (n = 9) ± standard deviation. Different letters 484 
denote signiﬁcant differences (p < 0.05) between samples of the same column. 485 
 486 
 487 
 488 
 489 
 490 
 491 
 492 
 493 
 494 
 495 
 496 
 497 
 498 
 499 
 500 
 501 
 502 
 
Incubation time (h) 
72  
BSA 1.01 ± 0.08b  
BSA+MGO 1.68 ± 0.13a  
BSA+MGO+CGA 0.51 ± 0.08c  
BSA+CGA 0.84 ± 0.19b,c  
21 
 
Fig. 1: (a) RP-HPLC chromatograms of CGA (10 mM) incubated at pH 7.4, 37 ºC during 24 h 503 
(upper panel) and freshly prepared (lower panel). Peak 1: neochlorogenic acid; Peak 2: 504 
cryptochlorogenic acid; Peak 3: chlorogenic acid (b) MALDI-TOF spectra of incubated at pH 7.4, 505 
37 ºC for 24 h (upper panel) and freshly prepared CGA (lower panel).  506 
a 507 
 508 
b 509 
 510 
 511 
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 512 
Fig. 2: Changes in the content of free amino groups in samples of control (BSA), BSA with MGO 513 
(BSA+MGO), BSA with MGO and CGA (BSA+MGO+CGA) and BSA with CGA (BSA+CGA) 514 
incubated at pH 7.4, 37 ˚C at different times during 192 h. Concentrations assayed were 1 mg mL-515 
1 BSA, 5 mM MGO and 10 mM CGA.  Data are means of triplicate analyses (n=9). Error bars 516 
denote the relative standard deviation. Different letters indicate significant differences (p < 0.001) 517 
within model systems at different times. BSA data are considered as references. 518 
 519 
 520 
 521 
 522 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
a a a
a
b
b b b
c c c c
c c c c
0
50
100
150
200
24 72 96 192
µ
g
  
N
α
-L
-A
ce
ti
l-
ly
si
n
e 
m
g
--
1
p
ro
te
in
Incubation time (h)
BSA BSA+MGO BSA+MGO+CGA BSA+CGA
23 
 
Fig. 3: Time-course of fluorescent AGE formation in samples of control (BSA), BSA with MGO 530 
(BSA+MGO), BSA with MGO and CGA (BSA+MGO+CGA) and BSA with CGA (BSA+CGA) 531 
incubated at pH 7.4 and 37 ˚C at different times during 192 h. Concentrations assayed were 1 mg 532 
mL-1 BSA, 5 mM MGO and 10 mM CGA. Data represent relative fluorescence units (RFU) (λexc 533 
360 nm, λem 440 nm). Bars represent mean values (n=9) and error bars represent standard 534 
deviation. Different letters denote signiﬁcant differences (p < 0.05) within model systems at the 535 
different times. 536 
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Fig. 4: Time-course of brown compound formation from control (BSA), BSA with MGO 550 
(BSA+MGO), BSA with MGO and CGA (BSA+MGO+CGA), BSA with CGA (BSA+CGA) and 551 
CGA control (CGA) incubated at pH 7.4, 37 ºC for 192 h. Concentrations assayed were 1 mg mL-552 
1 BSA, 5 mM MGO and 10 mM CGA. Data represent relative absorbance at 420 nm at different 553 
time points. Bars represent mean values (n=9) and error bars represent standard deviation. 554 
Different letters denote signiﬁcant differences (p < 0.05) within model systems at the different 555 
times. 556 
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Fig. 5: (a) UV-Vis absorption spectra and (b) content of phenol compounds bound to BSA isolated 567 
from samples corresponding to control (BSA), BSA with MGO (BSA+MGO), BSA with MGO 568 
and CGA (BSA+MGO+CGA), BSA with CGA (BSA+CGA) and CGA control (CGA) incubated 569 
at pH 7.4 and 37 ºC for 72 h. Concentrations assayed were 1 mg mL-1 BSA, 5 mM MGO and 10 570 
mM CGA. Bars represent mean values (n=9) and error bars represent standard deviation. Different 571 
letters denote signiﬁcant differences (p < 0.001) between means.  572 
a 573 
  574 
 b575 
 576 
 577 
a a
b
c
0
20
40
60
80
100
120
BSA BSA+MGO BSA+CGA BSA+MGO+CGA
µ
g
 e
q
-C
G
A
 m
L
-1
26 
 
Fig. 6: MALDI-TOF spectra of BSA control (a), BSA with MGO (b), BSA with CGA (c) and 578 
BSA with MGO and (d) incubated at pH 7.4 and 37 ˚C for 72h. Concentrations assayed were 1 579 
mg mL-1 BSA, 5 mM MGO and 10 mM CGA. 580 
 581 
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Fig. 7: Antioxidant capacity of the high molecular weight fractions isolated from samples of 582 
control (BSA), BSA with MGO (BSA+MGO), BSA with MGO and CGA (BSA+MGO+CGA), 583 
BSA with CGA (BSA+CGA) and CGA control (CGA) incubated at at pH 7.4 and 37 ˚C for 72 h. 584 
Concentrations assayed were 1 mg mL-1 BSA, 5 mM MGO and 10 mM CGA.. Data are expressed 585 
as g eq-CGA mL-1. Bars represent mean values (n=9) and error bars represent standard deviation. 586 
Different letters denote signiﬁcant differences (p < 0.001) between means. 587 
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